Summary
We have used intra-arterial (i.a.) 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) either alone or as part of adjuvant chemotherapy in patients with malignant brain tumors over a 3 year period (1979–1982). The i.a. BCNU technique was used 111 times to infuse 134 arteries in 37 patients. These patients, 28 cases with glial tumor and 9 cases with brain metastasis, received i.a. BCNU in combination with Vincristine and Procarbazine every 6 weeks. Complications encountered were transient and included: periorbital erythralgia or occipital-nuchal pain in 23 (62%), mild confusion and disorientation in 14 (38%), and ipsilateral conjunctival edema in 10 (27%). Reversible myelosuppression was not found. Our findings suggest that BCNU (100 Mg/M2) may be given by i.a. infusion in combination chemotherapy without persistent severe untoward effects with a cumulative dose of 700 mg/M2.
Similar content being viewed by others
References
Klopp CT, Alford TC, Bateman J, Berry GN, Winship T: Fractionated regional cancer chemotherapy with methyl bis amine hydrochloride: A preliminary report. Annals of Surg 132:811–832, 1950.
French JD, West PM, Von Amerungen FK, MCGoun HW: Effects of intracarotid administration of nitrogen mustard on normal brain and brain tumors. J Neurosurg 9:378–389, 1952.
Owens G, Javid R, Tallon M, Stepanian G, Belmusto L: Arterial infusion chemotherapy of primary gliomas. A report of thirty cases. JAMA 186:802–803, 1963.
Watkins E Jr, Sullivan RD: Cancer chemotherapy by prolonged arterial infusion. Surg Gyn & Obst 118:3–19, 1964.
Mahaley MS Jr, Woodhall B: Regional chemotherapeutic perfusion and infusion of brain and face tumors. Annals of Surg 166:266–277, 1967.
Crafts DC, Levin VA, Nielsen S: Intracarotid BCNU (NSC409962): A toxicity study in six rhesus monkeys. Cancer Treat Rep 61:541–545, 1976.
Fenstermacher JD, Cowles AL: Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61:519–526, 1977.
Levin VA, Kabra PM, Freeman-Dove MA: Pharmacokinetics of intracarotid artery 14C-BCNU in squirrel monkey. J Neurosurg 48:587–593, 1978.
Yamada K, Bremer AM, West CR, Ghoorah J, Park HC, Takita H: Intra-arterial BCNU therapy in the treatment of metastatic brain tumor from lung carcinoma. Cancer 44: 2000–2007, 1979.
Madajewicz S, West CR, park HC, Ghoorah J, Avellanosa AM, Takita H, Karakousis C, Vincent R, Caracandas J, Jennings E: Phase II study — Intra-arterial BCNU therapy for metastatic brain tumors. Cancer 47:653–657, 1981.
Greenberg HS, Ensminger WD, Seeger JF, Kindt GW, Chandler WF, Doan KM, Dakhil SR: Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: A preliminary report. Cancer Treat Rep 65:803–810, 1981.
Grimson BS, Mahaley MS Jr, Dubey HD, Dudka L: Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine). J Clin Neuro-ophthalmol 1:261–264, 1981.
Kapp J, Vance R, Parker JL, Smith RR: Limitations of high dose intra-arterial 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas. Neurosurgery 10: 713–719, 1982.
Phillips TW, Chandler WF, Kindt GW, Ensminger WD, Greenberg HS, Seeger JF, Doan KM, Gyves JW: New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas. Neurosurgery 11:213–218, 1982.
Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, 1949, pp 191–205.
Kapp JP, Ross RL, Tucker EM: Supraophthalmic carotid infusion for brain-tumor chemotherapy. Technical note. J Neurosurg 58:616–618, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bremer, A.M., Kleriga, E., Nguyen, T.Q. et al. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors. J Neuro-Oncol 2, 129–132 (1984). https://doi.org/10.1007/BF00177898
Issue Date:
DOI: https://doi.org/10.1007/BF00177898